SCHEMBL399417

SCHEMBL399417

Cc1ccccc1[OH+]c1ccccc1C.Fc1c(F)c(F)c([B-](c2c(F)c(F)c(F)c(F)c2F)(c2c(F)c(F)c(F)c(F)c2F)c2c(F)c(F)c(F)c(F)c2F)c(F)c1F

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.37
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.32
KDM4C Q9H3R0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
O-Xylene SCHEMBL30386408 0.81 TSHR (0.48) ACHETSHRHTTKDM4C
O-Xylene SCHEMBL30509215 0.81 TSHR (0.48) ACHETSHRHTTKDM4C
SCHEMBL399537 0.78 ACHE (0.33) ACHE
SCHEMBL30305775 0.76 ACHE (0.39) ACHETSHRHTTKDM4C
SCHEMBL7199265 0.74 ACHE (0.38) ACHETSHRHTTKDM4C
O-Tolylamine SCHEMBL578081 0.74 ACHE (0.38) ACHETSHRHTTKDM4C
SCHEMBL29628828 0.74 ACHE (0.38) ACHETSHRHTTKDM4C
SCHEMBL30468922 0.74 ACHE (0.38) ACHETSHRHTTKDM4C
SCHEMBL6609964 0.73 ACHE (0.37) ACHETSHRHTTKDM4C
SCHEMBL217304 0.73 ACHE (0.37) ACHETSHRHTTKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080153997-A1 Polymer production at supercritical conditions EXXONMOBIL RESEARCH AND ENGINEERING 2008-06-26 US claimed
US-20080033124-A1 Polymerization Process EXXONMOBIL CHEMICAL PATENTS INC. 2008-02-07 US claimed
US-12590174-B2 Curable compositions comprising telechelic polyolefins DOW GLOBAL TECHNOLOGIES LLC (US) 2026-03-31 US disclosed
EP-4688884-A1 PROCESS FOR PRODUCING BRANCHED POLYOLEFIN DOW GLOBAL TECHNOLOGIES LLC (US) 2026-02-11 EP disclosed
EP-4688882-A1 PROCESS FOR PRODUCING BRANCHED POLYOLEFIN DOW GLOBAL TECHNOLOGIES LLC (US) 2026-02-11 EP disclosed
EP-3902810-B1 CURABLE COMPOSITIONS COMPRISING TELECHELIC POLYOLEFINS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-14 EP disclosed
EP-3902808-B1 CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-01-14 EP disclosed
EP-4624501-A1 ETHYLENE ALPHA-OLEFIN COPOLYMER AND METHOD FOR PREPARING SAME LOTTE CHEMICAL CORPORATION (KR) 2025-10-01 EP disclosed
EP-4624502-A1 ETHYLENE ALPHA-OLEFIN COPOLYMER, METHOD FOR PREPARING SAME, AND RESIN COMPOSITION AND MOLDED ARTICLE COMPRISING SAME LOTTE CHEMICAL CORPORATION (KR) 2025-10-01 EP disclosed
EP-3356374-B1 MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2025-09-24 EP disclosed
EP-3902807-B1 ORGANOMETALLIC CHAIN TRANSFER AGENTS DOW GLOBAL TECHNOLOGIES LLC (US) 2025-07-09 EP disclosed
US-6420507-B1 COORDINATION CATALYSTS FOR POLYMERS THE DOW CHEMICAL COMPANY 2002-07-16 US disclosed
US-20020082161-A1 Diene functionalized catalyst supports and supported catalyst compositions THE DOW CHEMICAL COMPANY 2002-06-27 US disclosed
US-6376406-B1 COORDINATION POLYMERIZATION CATALYSTS FOR ALPHA-OLEFINS THE DOW CHEMICAL COMPANY 2002-04-23 US disclosed
US-6319979-B1 HAVING A DENSITY OF 0.850-0.895 G/CM.3 ; TACKIFYING RESIN; AND UP TO 40 WEIGHT PERCENT OF AT LEAST ONE WAX, VISCOSITY OF LESS THAN ABOUT 5000 CPS (50 GRAMS/(CM.SECOND)) AT 150 DEGREES C. THE DOW CHEMICAL COMPANY 2001-11-20 US disclosed
US-6284905-B1 GROUP 4 TRANSITION METAL COMPLEX CONTAINING A BORON OR ALUMINUM BRIDGING GROUP CONTAINING A NITROGEN CONTAINING ELECTRON DONATING GROUP, ESPECIALLY AN AMIDO GROUP; OLEFIN SOLUTION OR SLURRY POLYMERIZATION CATALYSTS THE DOW CHEMICAL COMPANY 2001-09-04 US disclosed
EP-0927187-A1 METAL COMPLEXES CONTAINING BRIDGED, NON-AROMATIC, ANIONIC, DIENYL GROUPS AND ADDITION POLYMERIZATION CATALYSTS THEREFROM THE DOW CHEMICAL COMPANY (US) 1999-07-07 EP disclosed
WO-1998003520-A1 METAL COMPLEXES CONTAINING BRIDGED, NON-AROMATIC, ANIONIC, DIENYL GROUPS AND ADDITION POLYMERIZATION CATALYSTS THEREFROM THE DOW CHEMICAL COMPANY (US) 1998-01-29 WO disclosed
WO-1996039451-A1 SEGMENTED MULTICOMPONENT INTERPOLYMERS OF MONOVINYLIDENE AROMATIC MONOMERS THE DOW CHEMICAL COMPANY (US) 1996-12-12 WO disclosed
US-5495036-A Metal (III) complexes containing conjugated, non-aromatic anionic II-bound groups and addition polymerization catalysts therefrom THE DOW CHEMICAL COMPANY (US) 1996-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590174-B2 Curable compositions comprising telechelic polyolefins CCT2, TCP1, ECH1 ACHE 1880/4885TSHR 1861/4885HTT 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.